At the heart of medical progress lies research that moves decisively from discovery to patient care.
Hadassah International supports and advances this work, ensuring that Hadassah hospitals’ scientific leadership continues to translate into real-world impact—locally in Israel and globally through collaboration, knowledge exchange, and sustained investment.
Research Embedded in Care
At Hadassah, research is not separate from medicine—it is fully integrated into clinical practice.
Every department at Hadassah hospitals maintains an active research arm, enabling physicians and scientists to investigate disease mechanisms, test new therapies, and rapidly translate findings into patient care. This integrated model allows discoveries made at the bench to reach the bedside with exceptional speed.
Hadassah hospitals researchers publish approximately 900 peer-reviewed scientific papers annually and receive more than half of all Israeli biomedical research grants awarded to hospitals, alongside competitive funding from the NIH, the European Union, and leading international foundations.
Leading the Future of Cancer Treatment with Precision Oncology and Immunotherapy
HADASSAH HOSPITALS is internationally recognized for its leadership in cancer research, particularly in immunotherapy and personalized medicine.
- The Hadassah Cancer Research Institute (HCRI) focuses on multi-layer tumor profiling, epigenetics, and immune-based therapies, drawing on one of Israel’s most comprehensive biobanks.
- Under the leadership of Prof. Michal Lotem, HADASSAH HOSPITALS has launched global initiatives advancing RNA-based cancer therapeutics, including the CanceRNA Consortium, a Hadassah-led international partnership supported by the EU Horizon-Health program.
- HADASSAH HOSPITALS pioneered Israel’s first engineered adoptive cell therapy for solid tumors with a homegrown CAR-T therapy for blood cancers developed by Prof. Polina Stepensky — expanding access to advanced treatments while reducing cost barriers.
These efforts are redefining how resistant and aggressive cancers are treated worldwide.
Harnessing Data, AI, and Digital Medicine
HADASSAH HOSPITALS is at the forefront of data-driven healthcare, deploying advanced artificial intelligence and digital infrastructure to improve diagnosis, prediction, and treatment personalization.
- AI algorithms are integrated across radiology, oncology, neurology, IVF, and emergency medicine.
- The Data Research Unit enables researchers to securely access decades of clinical data, supporting predictive models and early disease detection.
- In oncology and epilepsy, digital platforms now integrate imaging, pathology, genomics, and patient-reported outcomes into unified clinical decision tools.
These systems are transforming how clinicians anticipate risk, tailor therapies, and improve outcomes.
Regenerative Medicine and Stem Cell Breakthroughs
HADASSAH HOSPITALS has led pioneering work in regenerative medicine for more than two decades:
- Vision-restoring stem cell therapies for age-related macular degeneration
- Stem-cell-based treatments for ALS and multiple sclerosis, now advancing through FDA-approved international trials
- World-first models enabling the study of sex-based biological differences in stem cell research
These breakthroughs are opening new therapeutic pathways for diseases once considered untreatable.
The Organoid and Personalized Medicine Revolution
At the Hadassah Organoid Center, scientists grow miniature patient-derived tissues—organoids—that allow physicians to test drugs before prescribing them.
This approach enables:
- Personalized treatment selection
- Faster identification of effective therapies
- Expanded access to experimental treatments for patients with rare or resistant conditions
Precision medicine at Hadassah is no longer theoretical—it is already reshaping patient care.
Innovation That Extends Beyond the Lab
Hadassah hospitals’ innovation ecosystem includes hundreds of researchers, clinicians, and startups working on campus, advancing technologies in robotics, imaging, radiation therapy, and biomedical engineering.
From robotic spinal surgery to adaptive proton therapy systems, Hadassah researchers continue to push the boundaries of what modern medicine can achieve.
Why This Matters Globally
The challenges facing healthcare today—cancer resistance, neurodegeneration, aging populations, and system sustainability—require research that is bold, integrated, and collaborative.
Through the Hadassah hospitals, and with the support of Hadassah International, groundbreaking research becomes lasting medical progress—improving lives far beyond Jerusalem.
Advancing Discovery Through Partnership
Sustaining research of this caliber requires more than scientific excellence alone. It depends on long-term investment, international collaboration, and partners who recognize that medical progress is built over time.
Hadassah International invites philanthropic supporters, foundations, and institutional partners to join in advancing the Hadassah hospitals’s research leadership—supporting discovery, accelerating translation from laboratory to clinic, and opening new pathways for global collaboration. Together, we help ensure that bold ideas become lasting medical solutions, and that research conducted in Jerusalem continues to benefit patients and healthcare systems worldwide.
